PATENT CLAIM ANALYSIS

Application Number: 16103210
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "263200"]

Abstract:
Compounds having a structure according to formula (I) where R 1 , R 2 , and R 3  are as defined herein, are agonists for the Toll-like receptor 7 (TLR7) and can be used as adjuvants for stimulating the immune system. Some such compounds can be used in conjugates for targeted delivery to the organ or tissue of intended action.

Claim (Index 6):
A compound according to  claim 1 , selected from the group consisting of

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.36735
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16103511', '16103619', '16103601', '16103581', '15789027']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8219243942106668
- 35 USC 102 Novelty (BERT): 0.5330367359766159
- Combined Prediction Score: 0.7930356283872617
- Mean Citation Score: 331.26069399999994
- Max Citation Score: 353.1523
- Similarity Product: 345.99100158865457

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test